NEMO SurveyNEMO Survey

Please click here to participate in the European survey on management (including diagnosis and treatment) of neonatal seizures.


NEMO NewsletterNEMO Newsletter

Please click here

to read the 4th NEMO Newsletter.

Please click here

to read the 3rd NEMO Newsletter.

Please click here
to read the 2nd NEMO Newsletter.


NEMO project flyerNEMO project flyer

       

  Please click here
  to download the flyer.


ConsortiumConsortium
consortium teaser

QuicklinksQuicklinks
Download of information and forms Download of information and forms Educational tools for parents Educational tools for parents Educational tools for clinicians and health care professionals Educational tools for clinicians and health care professionals Coordinator/Project Office Coordinator/Project Office





SEVENTH FRAMEWORK PROGRAMME


Only For Children Pharmaceuticals

Only For Children Pharmaceuticals
35 bis rue Henri Barbuse
75005 Paris

France

O4CP www.o4cp.com



Teamleader


Dr, eMBA Vincent Grek Dr, eMBA Vincent Grek
Medical Doctor, EMBA; Drug development 
Phone: +33 1 75 00 02 87 
Fax: +33 1 43 26 18 81 
E-Mail to Dr, eMBA Vincent Grek Contact  
 



Project Staff


Dr, eMBA Estelle Habert-Ortoli Dr, eMBA Estelle Habert-Ortoli
Associated Director, pharmacological development 
Phone: +33 1 57 27 86 87 
Fax: +33 1 57 27 86 80 
E-Mail to Dr, eMBA Estelle Habert-Ortoli Contact  

Dr, Pharm D. Alice Nolla Dr, Pharm D. Alice Nolla
Head of Pharmacovigilance, Regulatory Affairs & Quality Assurance 
Phone: +33 1 57 27 89 90 
Fax: +33 1 57 27 57 10 
E-Mail to Dr, Pharm D. Alice Nolla Contact  


Institute Presentation


Only for children pharmaceuticals® (O4CP) is a French pharmaceutical company (SAS) founded in 2007 developing adapted medicines for children. The company addresses an important unmet medical need that experts and regulatory authorities have clearly identified: the need for adapted medicines for children.

Description of the laboratories involved within the organisation. Background and facilities:
O4CP is leading a cluster named "Forms4kids" dedicated to the development of paediatric medicines (see www.medicen.org). This cluster has all the facilities for drug development. Because of the heterogeneous needs of the paediatric population, O4CP has identified several manufacturers capable of specifically addressing this target population's needs.

Previous experience relevant to our tasks:
Coordinator of LOULLA&PHILLA FP7 project, O4CP responded to the call Health 4.2.1 (September 2007) and obtained 15 out of 15. Dr Vincent Grek, the contact person for O4CP, is a Medical Doctor and is currently founder and president of O4CP. He has 20 years of experience in Research, Medicine and in the Pharmaceutical Industry. Vincent Grek's areas of expertise include trials in special population (orphan, pædiatric, very severe population), development of biotech products (vaccine, enzyme, gene therapy), trial rescue, GCP (Good Clinical Practices), interaction with regulatory authorities (FDA, EMEA). He has a Doctor of Medicine degree with honors from the University of Liege (Belgium, 1989) and an executive MBA from ESSEC. He specialised in Internal Medicine with a focus on hemato-oncology, infectious diseases and intensive care (Belgium, 1994).



Only For Children Pharmaceuticals (O4CP)